Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
120 | 3 | DNA REPAIR//BRCA1//BRCA2 | 70548 |
236 | 2 | BRCA1//BRCA2//FANCONI ANEMIA | 19966 |
425 | 1 | BRCA2//BRCA1//HEREDITARY BREAST CANCER | 3508 |
2328 | 1 | CHK1//CHECKPOINT//RAD9 | 2317 |
2880 | 1 | DNA PK//NON HOMOLOGOUS END JOINING//DNA DEPENDENT PROTEIN KINASE | 2154 |
3391 | 1 | FANCONI ANEMIA//FANCONI ANAEMIA//FANCD2 | 2028 |
5007 | 1 | GAMMA H2AX//53BP1//H2AX | 1716 |
5308 | 1 | ATAXIA TELANGIECTASIA//ATM//ATM GENE | 1673 |
5866 | 1 | BRCA1//BARD1//BRCA2 | 1591 |
7545 | 1 | 8Q24//HEREDITARY PROSTATE CANCER//RNASEL | 1380 |
8223 | 1 | PARP INHIBITORS//OLAPARIB//BRCANESS | 1304 |
12371 | 1 | NIJMEGEN BREAKAGE SYNDROME//NBS1//MRE11 | 942 |
15784 | 1 | CHEK2//PALB2//CHK2 | 719 |
17316 | 1 | CANC GENET EPIDEMIOL//SERV CIRUGIA GEN ESPECIALIDADES//UNIT MOL BASES GENET RISK GENET TESTING | 634 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | BRCA1 | authKW | 1757768 | 9% | 65% | 1725 |
2 | BRCA2 | authKW | 1281904 | 6% | 73% | 1116 |
3 | FANCONI ANEMIA | authKW | 691604 | 3% | 78% | 566 |
4 | ATAXIA TELANGIECTASIA | authKW | 509461 | 2% | 74% | 436 |
5 | CHK1 | authKW | 259772 | 1% | 59% | 279 |
6 | PARP INHIBITORS | authKW | 218895 | 1% | 60% | 231 |
7 | DNA REPAIR | authKW | 210824 | 5% | 14% | 994 |
8 | BRCA | authKW | 184602 | 1% | 47% | 250 |
9 | HEREDITARY BREAST CANCER | authKW | 182772 | 1% | 67% | 173 |
10 | ATM | authKW | 174877 | 2% | 23% | 481 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 91010 | 36% | 1% | 7140 |
2 | Genetics & Heredity | 54407 | 22% | 1% | 4482 |
3 | Cell Biology | 30673 | 21% | 1% | 4259 |
4 | Biochemistry & Molecular Biology | 13633 | 25% | 0% | 4950 |
5 | Toxicology | 2732 | 4% | 0% | 852 |
6 | Hematology | 1651 | 4% | 0% | 715 |
7 | Biology | 974 | 3% | 0% | 538 |
8 | Biophysics | 818 | 3% | 0% | 688 |
9 | Obstetrics & Gynecology | 664 | 3% | 0% | 514 |
10 | Radiology, Nuclear Medicine & Medical Imaging | 547 | 3% | 0% | 671 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANC GENET EPIDEMIOL | 155899 | 1% | 54% | 184 |
2 | INT HEREDITARY CANC | 108293 | 1% | 51% | 135 |
3 | FAMILY CANC CLIN | 105608 | 1% | 54% | 125 |
4 | UNIT MOL BASES GENET RISK GENET TESTING | 86932 | 0% | 69% | 80 |
5 | GENOME DAMAGE STABIL | 69692 | 1% | 27% | 163 |
6 | PROGRAM CANC GENET | 64729 | 1% | 41% | 101 |
7 | CANC GENET TUMOR BIOL | 55023 | 0% | 78% | 45 |
8 | FAMILIAL BREAST OVARIAN CANC | 53284 | 0% | 69% | 49 |
9 | ONTARIO CANC GENET NETWORK | 52542 | 0% | 68% | 49 |
10 | MOL GENET BREAST CANC | 49726 | 0% | 66% | 48 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DNA REPAIR | 103168 | 2% | 18% | 371 |
2 | FAMILIAL CANCER | 61451 | 1% | 21% | 189 |
3 | BREAST CANCER RESEARCH AND TREATMENT | 40711 | 2% | 6% | 442 |
4 | HEREDITARY CANCER IN CLINICAL PRACTICE | 31982 | 0% | 33% | 62 |
5 | CELL CYCLE | 21470 | 1% | 6% | 232 |
6 | BREAST CANCER RESEARCH | 16436 | 1% | 7% | 154 |
7 | MOLECULAR CELL | 14363 | 1% | 4% | 230 |
8 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 11080 | 1% | 3% | 215 |
9 | ONCOGENE | 10908 | 2% | 2% | 367 |
10 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 9880 | 1% | 6% | 108 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BRCA1 | 1757768 | 9% | 65% | 1725 | Search BRCA1 | Search BRCA1 |
2 | BRCA2 | 1281904 | 6% | 73% | 1116 | Search BRCA2 | Search BRCA2 |
3 | FANCONI ANEMIA | 691604 | 3% | 78% | 566 | Search FANCONI+ANEMIA | Search FANCONI+ANEMIA |
4 | ATAXIA TELANGIECTASIA | 509461 | 2% | 74% | 436 | Search ATAXIA+TELANGIECTASIA | Search ATAXIA+TELANGIECTASIA |
5 | CHK1 | 259772 | 1% | 59% | 279 | Search CHK1 | Search CHK1 |
6 | PARP INHIBITORS | 218895 | 1% | 60% | 231 | Search PARP+INHIBITORS | Search PARP+INHIBITORS |
7 | DNA REPAIR | 210824 | 5% | 14% | 994 | Search DNA+REPAIR | Search DNA+REPAIR |
8 | BRCA | 184602 | 1% | 47% | 250 | Search BRCA | Search BRCA |
9 | HEREDITARY BREAST CANCER | 182772 | 1% | 67% | 173 | Search HEREDITARY+BREAST+CANCER | Search HEREDITARY+BREAST+CANCER |
10 | ATM | 174877 | 2% | 23% | 481 | Search ATM | Search ATM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |